ID

31481

Description

Lenalidomide, Vorinostat and Dexamethasone in Relapsed Patients With Peripheral T-Cell Non-Hodgkin's Lymphoma (PTCL); ODM derived from: https://clinicaltrials.gov/show/NCT00972842

Lien

https://clinicaltrials.gov/show/NCT00972842

Mots-clés

Versions (1)
  1. 27/08/2018 27/08/2018 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

27 août 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Peripheral T-Cell Non-Hodgkin's Lymphoma NCT00972842

Anglais

Eligibility Peripheral T-Cell Non-Hodgkin's Lymphoma NCT00972842

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with relapsed ptcl according to who criteria who have received max. two previous treatments for ptcl
Description

Peripheral T-Cell Lymphoma Relapsed | Prior Therapy Quantity Peripheral T-Cell Lymphoma

Type de données

boolean

Alias
UMLS CUI [1,1]
C0079774
UMLS CUI [1,2]
C0205336
UMLS CUI [2,1]
C1514463
UMLS CUI [2,2]
C1265611
UMLS CUI [2,3]
C0079774
age ≥ 18 years.
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
adequate bone marrow function i.e. absolute neutrophile count of > 1000/µl and thrombocytes > 75,000/µl.
Description

Bone Marrow function | Absolute neutrophil count | Platelet Count measurement

Type de données

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C0031843
UMLS CUI [2]
C0948762
UMLS CUI [3]
C0032181
alkaline phosphatase and transaminases ≤ 2,5 x upper limit of normal (uln)
Description

Alkaline phosphatase measurement | Transaminase Assay

Type de données

boolean

Alias
UMLS CUI [1]
C0201850
UMLS CUI [2]
C0919834
total bilirubin ≤ 2,5 x uln
Description

Serum total bilirubin measurement

Type de données

boolean

Alias
UMLS CUI [1]
C1278039
creatinine clearance ≥ 50 ml/min
Description

Creatinine clearance measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0373595
female subjects of childbearing potential† must: understand that the study medication could have an expected teratogenic risk and agree to use, and be able to comply with, effective contraception and agree to have a medically supervised pregnancy test
Description

Childbearing Potential Contraceptive methods | Comprehension Investigational New Drugs Risk Teratogenesis | Childbearing Potential Pregnancy Test

Type de données

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0700589
UMLS CUI [2,1]
C0162340
UMLS CUI [2,2]
C0013230
UMLS CUI [2,3]
C0035647
UMLS CUI [2,4]
C0232910
UMLS CUI [3,1]
C3831118
UMLS CUI [3,2]
C0032976
male subjects must agree to use condoms and agree not to donate semen
Description

Gender | Male condom contraception | Sperm donation Absent

Type de données

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0850360
UMLS CUI [3,1]
C0871414
UMLS CUI [3,2]
C0332197
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior history of malignancies, other than ptcl, unless the subject has been free of the disease for ≥ 3 years
Description

Cancer Other | Exception Disease Free of

Type de données

boolean

Alias
UMLS CUI [1]
C1707251
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0012634
UMLS CUI [2,3]
C0332296
prior allogeneic bone marrow transplant or plans to undergo autologous/ allogeneic bone marrow transplant within 4 weeks of the initiation of vorinostat administration
Description

Allogeneic bone marrow transplantation | Autologous bone marrow transplant Planned | Allogeneic bone marrow transplantation Planned

Type de données

boolean

Alias
UMLS CUI [1]
C0149615
UMLS CUI [2,1]
C0194037
UMLS CUI [2,2]
C1301732
UMLS CUI [3,1]
C0149615
UMLS CUI [3,2]
C1301732
prior treatment with a hdac inhibitor
Description

Histone deacetylase inhibitor

Type de données

boolean

Alias
UMLS CUI [1]
C1512474
prior treatment with lenalidomide (patients previously treated with thalidomide may be enrolled)
Description

Lenalidomide | Prior Therapy Thalidomide allowed

Type de données

boolean

Alias
UMLS CUI [1]
C1144149
UMLS CUI [2,1]
C1514463
UMLS CUI [2,2]
C0039736
UMLS CUI [2,3]
C0683607
known history of deep vein thrombosis (dvt) and/ or pulmonary embolism (pe)
Description

Deep Vein Thrombosis | Pulmonary Embolism

Type de données

boolean

Alias
UMLS CUI [1]
C0149871
UMLS CUI [2]
C0034065
Retour au début de la page

Similar models

Eligibility Peripheral T-Cell Non-Hodgkin's Lymphoma NCT00972842

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Peripheral T-Cell Lymphoma Relapsed | Prior Therapy Quantity Peripheral T-Cell Lymphoma
Item
patients with relapsed ptcl according to who criteria who have received max. two previous treatments for ptcl
boolean
C0079774 (UMLS CUI [1,1])
C0205336 (UMLS CUI [1,2])
C1514463 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0079774 (UMLS CUI [2,3])
Age
Item
age ≥ 18 years.
boolean
C0001779 (UMLS CUI [1])
Bone Marrow function | Absolute neutrophil count | Platelet Count measurement
Item
adequate bone marrow function i.e. absolute neutrophile count of > 1000/µl and thrombocytes > 75,000/µl.
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C0948762 (UMLS CUI [2])
C0032181 (UMLS CUI [3])
Alkaline phosphatase measurement | Transaminase Assay
Item
alkaline phosphatase and transaminases ≤ 2,5 x upper limit of normal (uln)
boolean
C0201850 (UMLS CUI [1])
C0919834 (UMLS CUI [2])
Serum total bilirubin measurement
Item
total bilirubin ≤ 2,5 x uln
boolean
C1278039 (UMLS CUI [1])
Creatinine clearance measurement
Item
creatinine clearance ≥ 50 ml/min
boolean
C0373595 (UMLS CUI [1])
Childbearing Potential Contraceptive methods | Comprehension Investigational New Drugs Risk Teratogenesis | Childbearing Potential Pregnancy Test
Item
female subjects of childbearing potential† must: understand that the study medication could have an expected teratogenic risk and agree to use, and be able to comply with, effective contraception and agree to have a medically supervised pregnancy test
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0162340 (UMLS CUI [2,1])
C0013230 (UMLS CUI [2,2])
C0035647 (UMLS CUI [2,3])
C0232910 (UMLS CUI [2,4])
C3831118 (UMLS CUI [3,1])
C0032976 (UMLS CUI [3,2])
Gender | Male condom contraception | Sperm donation Absent
Item
male subjects must agree to use condoms and agree not to donate semen
boolean
C0079399 (UMLS CUI [1])
C0850360 (UMLS CUI [2])
C0871414 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
Item Group
C0680251 (UMLS CUI)
Cancer Other | Exception Disease Free of
Item
prior history of malignancies, other than ptcl, unless the subject has been free of the disease for ≥ 3 years
boolean
C1707251 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0012634 (UMLS CUI [2,2])
C0332296 (UMLS CUI [2,3])
Allogeneic bone marrow transplantation | Autologous bone marrow transplant Planned | Allogeneic bone marrow transplantation Planned
Item
prior allogeneic bone marrow transplant or plans to undergo autologous/ allogeneic bone marrow transplant within 4 weeks of the initiation of vorinostat administration
boolean
C0149615 (UMLS CUI [1])
C0194037 (UMLS CUI [2,1])
C1301732 (UMLS CUI [2,2])
C0149615 (UMLS CUI [3,1])
C1301732 (UMLS CUI [3,2])
Histone deacetylase inhibitor
Item
prior treatment with a hdac inhibitor
boolean
C1512474 (UMLS CUI [1])
Lenalidomide | Prior Therapy Thalidomide allowed
Item
prior treatment with lenalidomide (patients previously treated with thalidomide may be enrolled)
boolean
C1144149 (UMLS CUI [1])
C1514463 (UMLS CUI [2,1])
C0039736 (UMLS CUI [2,2])
C0683607 (UMLS CUI [2,3])
Deep Vein Thrombosis | Pulmonary Embolism
Item
known history of deep vein thrombosis (dvt) and/ or pulmonary embolism (pe)
boolean
C0149871 (UMLS CUI [1])
C0034065 (UMLS CUI [2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial